Forian Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
March 27, 2023 at 04:35 pm EDT
Share
Forian Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 7.9 million compared to USD 5.75 million a year ago. Net loss was USD 3.56 million compared to USD 8.05 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.22 a year ago. Diluted loss per share from continuing operations was USD 0.11 compared to USD 0.22 a year ago.
For the full year, revenue was USD 28.01 million compared to USD 16.88 million a year ago. Net loss was USD 25.97 million compared to USD 26.55 million a year ago. Basic loss per share from continuing operations was USD 0.81 compared to USD 0.9 a year ago. Diluted loss per share from continuing operations was USD 0.81 compared to USD 0.9 a year ago.
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. The Companyâs operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. The Companyâs offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries.